Bipolar I Disorder

Bipolar I Disorder is defined by the occurrence of at least one manic episode: a distinct period of abnormally elevated, expansive, or irritable mood combined with a marked increase in energy and activity, severe enough to cause significant impairment, require hospitalization, or involve psychotic features. While most people with Bipolar I also experience major depressive episodes over their lifetime, depression is not required for the diagnosis — a single manic episode is sufficient. Between episodes, many people return to their usual level of functioning, though the illness carries a substantial risk of relapse and, notably, one of the highest suicide risks of any psychiatric condition.

Bipolar I Disorder requires at least one manic episode: a distinct period lasting at least one week (or any duration if hospitalization is required) of abnormally and persistently elevated, expansive, or irritable mood and increased goal-directed activity or energy, accompanied by three or more (four if the mood is only irritable) characteristic symptoms, causing marked impairment in functioning, necessitating hospitalization, or including psychotic features.

Bipolar I Disorder has one of the strongest genetic contributions among major psychiatric conditions, with heritability estimated at 60–80%. It is thought to arise from dysregulation of dopamine signaling (particularly during manic episodes) and disruption of the brain's circadian rhythm regulation. According to the 'kindling' model, episodes can become more frequent and increasingly spontaneous (requiring less external trigger) over time if the illness goes untreated, which is part of why early, sustained treatment matters.

• Family history of bipolar disorder (the strongest known risk factor)
• History of postpartum psychosis
• Significant sleep deprivation
• Stimulant or other substance use
• Antidepressant use without a mood stabilizer, which can trigger a manic episode
• High-stress or highly stimulating life events
• Seasonal patterns in some individuals

Manic episodes are associated with dopaminergic hyperactivity, which underlies the effectiveness of antipsychotic medications in acute treatment. Structural and functional imaging studies show abnormalities in the connectivity between the prefrontal cortex (responsible for emotional regulation and judgment) and limbic structures like the amygdala, impairing the brain's ability to regulate mood swings. Genetic research has also implicated circadian rhythm genes (such as CLOCK), consistent with the central role sleep disruption plays in triggering episodes.

• Manic episode: elevated, expansive, or irritable mood with high energy
• Inflated self-esteem or grandiosity
• Decreased need for sleep (e.g., feeling rested after only 3 hours)
• More talkative than usual, or pressured speech
• Racing thoughts or flight of ideas
• Distractibility
• Increased goal-directed activity or psychomotor agitation
• Excessive involvement in risky activities (spending sprees, impulsive sexual behavior, risky investments)
• Depressive episodes (in most patients over their lifetime), resembling Major Depressive Disorder
• Psychotic features (delusions or hallucinations) possible during severe mania or depression

• At least one manic episode: elevated/expansive/irritable mood plus increased energy/activity lasting 1 week or more (or any duration if hospitalization is required)
• Three or more characteristic symptoms (four if mood is irritable only) during the episode
• The episode causes marked impairment, requires hospitalization, or includes psychotic features
• Not attributable to a substance or another medical condition

Conditions a psychiatrist will consider and rule out before confirming this diagnosis:

Bipolar II Disorder

Involves hypomanic (not full manic) episodes; the presence of even one true manic episode reclassifies the diagnosis as Bipolar I.

Schizoaffective Disorder

Psychotic symptoms are present even outside of mood episodes, unlike bipolar disorder where psychosis, if present, occurs only during severe mood episodes.

Substance-induced mood disorder

Stimulants, corticosteroids, or other substances can produce manic-like symptoms that resolve once the substance is stopped.

ADHD

Shares features like distractibility and high energy, but follows a chronic, early-childhood-onset course rather than the episodic pattern of mania.

Borderline Personality Disorder

Mood shifts in BPD are typically brief (hours) and reactive to interpersonal triggers, unlike the sustained, days-to-weeks mood episodes of bipolar disorder.

Hyperthyroidism

Can cause symptoms resembling mania (restlessness, rapid speech, insomnia); thyroid function tests help exclude this.

• Detailed clinical interview and longitudinal mood history, often supplemented by collateral history from family (insight is frequently reduced during mania)
• Mood Disorder Questionnaire (MDQ) as a screening tool
• Thyroid function tests
• Urine toxicology screening to exclude stimulant-induced symptoms
• Mood charting over time to establish the episodic pattern

Mood stabilizers form the cornerstone of both acute and long-term treatment, with lithium remaining the gold-standard option, notably also reducing suicide risk. Acute severe mania, especially with psychotic features, often requires an atypical antipsychotic and may require hospitalization for safety. Antidepressants are generally avoided as monotherapy, since they carry a risk of triggering mania or accelerating episode cycling if not combined with a mood stabilizer.

Lithium

The gold-standard mood stabilizer for both acute mania and long-term maintenance; also specifically reduces suicide risk, requiring regular blood level and kidney/thyroid monitoring.

Valproate (divalproex)

An effective mood stabilizer, particularly for acute mania.

Atypical antipsychotics (e.g., olanzapine, quetiapine, risperidone, aripiprazole)

Used for acute mania and often continued for maintenance treatment.

Lamotrigine

More effective for preventing depressive episodes and maintenance than for treating acute mania.

Psychoeducation

Critical for recognizing early warning signs of an emerging episode (changes in sleep, spending, mood) and supporting treatment adherence.

Interpersonal and Social Rhythm Therapy (IPSRT)

Focuses on stabilizing daily routines and sleep-wake timing, which helps prevent episode triggers.

Family-Focused Therapy

Involves the family in recognizing warning signs and improving communication and support around the illness.

Cognitive Behavioral Therapy

Used as an adjunct, particularly for managing depressive symptoms and relapse prevention.

• Maintain a strict, regular sleep schedule — sleep deprivation is one of the most powerful triggers of mania
• Avoid alcohol and recreational drugs, which can destabilize mood
• Track mood, sleep, and energy daily to notice early warning signs
• Maintain consistent daily routines and manage stress proactively
• Prioritize medication adherence even when feeling well, since stopping treatment is a leading cause of relapse

Bipolar I Disorder is a chronic, relapsing condition, but with consistent treatment — especially lithium or another mood stabilizer — many people achieve good long-term functional stability. Left untreated, the illness tends to have a high relapse rate and can lead to progressive functional decline. Suicide risk is significantly elevated compared to the general population, making ongoing treatment and monitoring especially important.

• Early recognition and treatment of the first manic or depressive episode
• Consistent maintenance mood stabilizer treatment, even during periods of stability
• Protecting regular sleep patterns, particularly during high-stress periods
• Avoiding known triggers such as stimulant use or unopposed antidepressant treatment
• Family psychoeducation to recognize early prodromal signs of relapse

Learn the early warning signs of both mania (reduced sleep need, increased spending, grandiosity, irritability) and depression, since early intervention can prevent a full-blown episode. Avoid taking behavior during an acute episode personally — it is driven by the illness, not the person's true character or feelings toward you. Medication adherence is often the biggest challenge, since a person feeling well (or even mildly elevated) may feel they no longer need treatment; gentle, consistent support and involvement in a relapse-prevention plan is more effective than confrontation. Have a safety plan in place for periods of acute risk.

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, Text Revision (DSM-5-TR).
2. World Health Organization. International Classification of Diseases, 11th Revision (ICD-11).
3. National Institute for Health and Care Excellence (NICE). Bipolar disorder: assessment and management.